Skip to Content

Plus Pharma Senna Plus Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each

Dosage form: tablet, film coated
Ingredients: DOCUSATE SODIUM 50mg, SENNOSIDES 8.6mg
Labeler: Gemini Pharmaceuticals, Inc. dba Plus Pharma
NDC Code: 51645-850

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Senna Plus Tablets

Drug Facts

Active ingredients (in each tablet)

Docusate Sodium 50 mg

Sennosides 8.6 mg

Purposes

Stool softener

Laxative

Uses

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 6-12 hours

Warnings

Do not use

  • if you are now taking mineral oil, unless directed by a doctor
  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative.

These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • take preferably at bedtime or as directed by a doctor
agestarting dosemaximum dose
adults and children 12 years and older
2 tablets once a day
4 tablets twice a day
children 6 to under 12 years
1 tablet once a day
2 tablets twice a day
children 2 to under 6 years
1/2 tablet once a day
1 tablet twice a day
children under 2 years
ask a doctor
ask a doctor

Other information

  • each tablet contains: calcium 20 mg
  • each tablet contains: sodium4 mg
  • store at room temperature in a dry place
  • keep lid tightly closed

Inactive ingredients Croscarmellose sodium, D&C yellow #10, dextrose, dicalcium phosphate, FD&C yellow #6, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, silica, sodium benzoate, stearic acid, titanium dioxide.

Questions? If you have any questions or comments, or to report an adverse event, please contact (800) 795-9775.

DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Distributed by:

Plus Pharma

Commack, NY 11725

Manufactured in a GMP facility in the USA

NDC 51645-850-10

Plus PHARMA

Senna Plus

Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each

Vegetable Laxative Ingredient Plus Stool Softener

Contains no ingredient made from a gluten-containing grain (wheat, barley, or rye).

*Compare to the Active Ingredients in Senokot-S®

*Plus Pharma is not affiliated with the owner of the registered trademark Senokot-S®

1000 TABLETS

PLUS PHARMA SENNA PLUS  STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH
docusate sodium,sennosides tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51645-850
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM50 mg
SENNOSIDES (SENNOSIDES) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM 
D&C YELLOW NO. 10 
DEXTROSE 
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE 
FD&C YELLOW NO. 6 
HYPROMELLOSES 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
POLYETHYLENE GLYCOLS 
SILICON DIOXIDE 
SODIUM BENZOATE 
STEARIC ACID 
TITANIUM DIOXIDE 
Product Characteristics
ColororangeScoreno score
ShapeROUND (Biconvex) Size10mm
FlavorImprint CodeG55
Contains    
Packaging
#Item CodePackage Description
1NDC:51645-850-0660 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
2NDC:51645-850-101000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
3NDC:51645-850-9910 BLISTER PACK in 1 CARTON
310 TABLET, FILM COATED in 1 BLISTER PACK
4NDC:51645-850-01100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33403/27/2006
Labeler - Gemini Pharmaceuticals, Inc. dba Plus Pharma (055942270)
Establishment
NameAddressID/FEIOperations
Gemini Pharmaceuticals, Inc. dba Plus Pharma055942270manufacture(51645-850)

 
Gemini Pharmaceuticals, Inc. dba Plus Pharma

Medically reviewed on Jun 27, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide